Nasdaq-listed Predictive Oncology Inc. announced the completion of two private equity capital raises (PIPEs) to launch its digital asset library strategy. The company plans to center this strategy on ATH, the native token of the Aethir ecosystem.
Predictive Oncology will raise approximately $344.4 million in total capital through both cash and crypto‑asset‑based PIPEs. Under the cash PIPE, the company will issue approximately 66.7 million shares of common stock (or pre‑purchase warrants) at a price of $0.7751 per share, generating gross cash inflows of approximately $51.7 million.
Under the crypto PIPE, the company will issue up to 223.6 million pre‑purchase warrants. These warrants will be offered at a $0.01 discount to the per‑share issue price, representing a par value of approximately $292.7 million. Transactions will be made using contributions of locked and unlocked Aethir (ATH) tokens, representing a discounted value of approximately $173.3 million.
The pre‑purchase warrants under the cryptocurrency PIPE will be immediately exercisable upon the Company's receipt of shareholder approval. Both PIPEs are expected to close simultaneously around October 2, 2025, subject to the satisfaction of all necessary closing conditions.
Predictive Oncology plans to use the contribution from Aethir for its digital asset library strategy and the net proceeds from the PIPEs for ATH token purchases, working capital, and general corporate purposes.
*This is not investment advice.